Arsenic trioxide regulates the production and activities of matrix metalloproteinases-1, -2, and -9 in fibroblasts and THP-1

Chinese Medical Journal

Volumn 125, Issue 24, 2012, Pages 4481-4487

  Liang, Ya Hui ^a,b   Li, Ping ^a   Zhao, Jing Xia ^a   Dai, Miao Ke ^a   Huang, Qi Fu ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Rehabilitation Center   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Arsenic trioxide; Enzyme activity; Fibroblast; Matrix metalloproteinase; THP 1

Indexed keywords

ARSENIC TRIOXIDE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MONOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; WESTERN BLOTTING; ZYMOGRAPHY;

ARSENICALS; CELL LINE; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLASTS; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MONOCYTES; OXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874323288     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.24.029     Document Type: Article

References (29)

1. Xue M, Le NT, Jackson CJ. Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin Ther Targets 2006; 10: 143-155. (Pubitemid 43263272)
2. Trengove NJ, Stacey MC, MacAuley S. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999; 7:442-452. (Pubitemid 30027566)
3. Xue QS, Xiao YP, eds. Philosophy and technique of culture in vitro. Beijing: Science Publishing Company; 2001: 442-445.
4. Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair. Int J Mol Med 2000; 6: 391-407.
5. Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil 2005; 26: 306-319. (Pubitemid 41074514)
6. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 1993; 166: 74-81. (Pubitemid 23281429)
7. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg 1998; 25: 341-356. (Pubitemid 28343176)
8. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and nondiabetic patients. Diabetologia 2002; 45: 1011-1016. (Pubitemid 34762196)
9. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996; 107: 743-748. (Pubitemid 26371092)
10. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101:64-68. (Pubitemid 23213014)
11. Barone EJ, Yager DR, Pozez AL, Olutoye OO, Crossland MC, Diegelmann RF, et al. Interleukin-la and collagenase activity elevated in chronic wounds. Plast Reconstr Surg 1998; 102: 1023-1027. (Pubitemid 128723393)
12. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Konttinen YT. Matrix metalloproteinases, Gelatinase and Collagenase, in chronic leg ulcers. J Invest Dermatol 1996; 106: 1119-1124. (Pubitemid 26155102)
13. Drinkwater SL, Smith A, Burnand KG What can wound fluids tell us about the venous ulcer microenvironment? Int J Low Extrem Wounds 2002; 1: 184-190.
14. Mwaura B, Mahendran B, Hynes N, Defreitas D, Avalos G, Adegbola T, et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and PDGF-AA on the chronicity of venous leg ulcers. Eur J Vase Endovasc Surg 2006; 31: 306-310. (Pubitemid 43263515)
15. Parks WC. Matrix metalloproteinases in repair. Wound Repair Reg 1999; 7: 423-432. (Pubitemid 30027564)
16. Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol 2007; 25: 19-25. (Pubitemid 46177472)
17. Subramaniam K, Pech CM, Stacey MC, Wallace HJ. Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid. Int Wound J 2008; 5: 79-86. (Pubitemid 351379721)
18. Kanangat S, Postlethwaite A, Hasty K, Kang A, Smeltzer M, Appling W, et al. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther 2006; 8: Rl 76.
19. Huang X. The revival of the ancient drug-arsenic. Chin Med J 2003; 116: 1637-1638.
20. Park MJ, Lee JY, Kwak HJ, Park CM, Lee HC, Woo SH, et al. Arsenic trioxide (AS2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J Cell Biochem 2005; 95: 955-969. (Pubitemid 41420143)
21. Zhang J, Wang B. Arsenic trioxide (AS2O3) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo. Gynecol Oncol 2006; 103: 199-206. (Pubitemid 44374690)
22. Yu J, Qian H, Li Y, Wang Y, Zhang X, Liang X, et al. Arsenic trioxide (AS2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. Gynecol Oncol 2007; 106: 400-406. (Pubitemid 47096659)
23. Wei LH, Lai KP, Chen CA, Cheng CH, Huang YJ, Chou CH, et al. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappa B. Oncogene 2005; 4: 390-398.
24. Zhou LF, Zhu Y, Cui XF, Xie WP, Hu AH, Yin KS. Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation. Respir Res 2006; 7: 146-157.
25. Xue DB, Zhang WH, Yun XG, Song C, Zheng B, Shi XY, et al. Regulating effects of arsenic trioxide on cell death pathways and inflammatory reactions of pancreatic acinar cells in rats. Chin Med J 2007; 120: 690-695. (Pubitemid 46767805)
26. Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J 2004; 23: 671-678. (Pubitemid 38618134)
27. Schwende H, Fitzke E, Ambs P, Dieter P. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1, 25-dihydroxyvitamin D3. J Leukoc Biol 1996; 59: 555-561. (Pubitemid 26156616)
28. Liang YH, Li P, Huang QF, Zhang W, Sheng X, Liang DY. Effects of arsenic trioxide on activities of MMPs and expression of TIMP-1 and TGF-01 in skin fibroblasts and polymorphonuclear neutrophils. Chin J Pathophysiol (Chin) 2008;24:2209-2213.
29. Jiang JL, Chen ZN, Jia JF, Ye H, Tang H, Yao XY, et al. Effects of CD 147 on the release and activation of matrix metalloproteinases in co-cultured THP-1 with HFC in vitro. Chin J Rheumatol 2005; 9: 269-272.